Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Heymann

Showing results (11-20 of 243) with videos related to

Pageof 25
Sort By:
Drug Discovery Today|November 28, 2001
Osteoprotegerin: a new therapeutic agent for the treatment of bone diseaseEva Grimaud, Françoise Redini, Dominique Heymann
Trends in Molecular Medicine|September 11, 2009
Mechanisms of bone repair and regenerationFrédéric Deschaseaux, Luc Sensébé, Dominique Heymann
Expert Review of Anticancer Therapy|February 19, 2008
Liposomal muramyl tripeptide phosphatidyl ethanolamine: a safe and effective agent against osteosarcoma pulmonary metastasesKanji Mori, Kosei Ando, Dominique Heymann
Cytokine & Growth Factor Reviews|December 19, 2002
Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disordersEva Grimaud, Dominique Heymann, Françoise Rédini
Bone|July 6, 2020
Bisphosphonates in common pediatric and adult bone sarcomasMarie-Francoise Heymann, Frederic Lezot, Dominique Heymann
Cellular Immunology|November 10, 2017
The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcomaMarie-Françoise Heymann, Frédéric Lézot, Dominique Heymann
Regional Anesthesia and Pain Medicine|July 4, 2009
Useful side handle for holding needle during ultrasound-guided regional anesthesiaCharles Pham Dang, Paul Pilet, Dominique Heymann
British Journal of Pharmacology|January 25, 2020
Bone sarcomas in the immunotherapy eraMarie-Françoise Heymann, Kristina Schiavone, Dominique Heymann
Cancer Letters|November 30, 2016
Cancer stem cells in osteosarcomaHannah K Brown, Marta Tellez-Gabriel, Dominique Heymann
International Journal of Cancer|March 30, 2006
Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survivalFrançois Gouin, Benjamin Ory, François Rédini, et al.
Pageof 25

Showing results (11-20 of 243) with videos related to

Sort By:
Pageof 25
Drug Discovery Today|November 28, 2001
Osteoprotegerin: a new therapeutic agent for the treatment of bone diseaseEva Grimaud, Françoise Redini, Dominique Heymann
Trends in Molecular Medicine|September 11, 2009
Mechanisms of bone repair and regenerationFrédéric Deschaseaux, Luc Sensébé, Dominique Heymann
Expert Review of Anticancer Therapy|February 19, 2008
Liposomal muramyl tripeptide phosphatidyl ethanolamine: a safe and effective agent against osteosarcoma pulmonary metastasesKanji Mori, Kosei Ando, Dominique Heymann
Cytokine & Growth Factor Reviews|December 19, 2002
Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disordersEva Grimaud, Dominique Heymann, Françoise Rédini
Bone|July 6, 2020
Bisphosphonates in common pediatric and adult bone sarcomasMarie-Francoise Heymann, Frederic Lezot, Dominique Heymann
Cellular Immunology|November 10, 2017
The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcomaMarie-Françoise Heymann, Frédéric Lézot, Dominique Heymann
Regional Anesthesia and Pain Medicine|July 4, 2009
Useful side handle for holding needle during ultrasound-guided regional anesthesiaCharles Pham Dang, Paul Pilet, Dominique Heymann
British Journal of Pharmacology|January 25, 2020
Bone sarcomas in the immunotherapy eraMarie-Françoise Heymann, Kristina Schiavone, Dominique Heymann
Cancer Letters|November 30, 2016
Cancer stem cells in osteosarcomaHannah K Brown, Marta Tellez-Gabriel, Dominique Heymann
International Journal of Cancer|March 30, 2006
Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survivalFrançois Gouin, Benjamin Ory, François Rédini, et al.
Pageof 25